Whether you’re gearing up for a clinical trial or testing potential treatments, understanding how natural history studies track the course of a disease over time can be vital to drug development. Learn from Erika De Boever, deputy director of the Orphan Disease Center at the University of Pennsylvania, as she discusses how natural history data can inform clinical trials for rare disease. | 
No hay comentarios:
Publicar un comentario